Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2477952 | Annales Pharmaceutiques Françaises | 2015 | 6 Pages |
Abstract
Only a PICC Line in outpatients can be reimbursed by the health insurance; which amounts to 110.4 â¬. The establishment therefore loses money with every implantation. However, PICC Lines offer to the patients a fast access to a central venous way and thus an optimal therapeutic care, fulfilling one of the main missions of the public health institutions. Implanted subcutaneous ports are economically worth being implanted only in ambulatory inpatients. Its implantation in radiology seemed more profitable because the indirect costs were much more moderate.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
H. Viart, C. Combe, T. Martinelli, J. Thomas, H. Hida,